SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-003172
Filing Date
2024-05-09
Accepted
2024-05-09 17:00:35
Documents
45
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 3-31-24 xenetic_i10q-033124.htm   iXBRL 10-Q 392842
2 CERTIFICATION xenetic_10q-3101.htm EX-31.1 9585
3 CERTIFICATION xenetic_10q-3102.htm EX-31.2 9736
4 CERTIFICATION xenetic_10q-3201.htm EX-32.1 4747
  Complete submission text file 0001683168-24-003172.txt   2353074

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20240331.xsd EX-101.SCH 19159
6 XBRL CALCULATION FILE xbio-20240331_cal.xml EX-101.CAL 24635
7 XBRL DEFINITION FILE xbio-20240331_def.xml EX-101.DEF 108543
8 XBRL LABEL FILE xbio-20240331_lab.xml EX-101.LAB 198510
9 XBRL PRESENTATION FILE xbio-20240331_pre.xml EX-101.PRE 164814
48 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-033124_htm.xml XML 183020
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 24931695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)